Discontinued — last reported Q1 '18
Allowance for Doubtful Accounts Receivable (Current)
Medtronic Allowance for Doubtful Accounts Receivable (Current) increased by 3.5% to $207.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.5%, from $204.00M to $207.00M. Over 4 years (FY 2021 to FY 2025), Allowance for Doubtful Accounts Receivable (Current) shows a downward trend with a -4.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
Detailed definition
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Peer comparison
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_currentHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $257.00M | $255.00M | $253.00M | $230.00M | $219.00M | $203.00M | $207.00M | $176.00M | $190.00M | $177.00M | $180.00M | $173.00M | $170.00M | $195.00M | $204.00M | $199.00M | $204.00M | $200.00M | $207.00M |
| QoQ Change | — | -0.8% | -0.8% | -9.1% | -4.8% | -7.3% | +2.0% | -15.0% | +8.0% | -6.8% | +1.7% | -3.9% | -1.7% | +14.7% | +4.6% | -2.5% | +2.5% | -2.0% | +3.5% |
| YoY Change | — | — | — | — | -14.8% | -20.4% | -18.2% | -23.5% | -13.2% | -12.8% | -13.0% | -1.7% | -10.5% | +10.2% | +13.3% | +15.0% | +20.0% | +2.6% | +1.5% |
Allowance for Doubtful Accounts Receivable (Current) at Other Companies
Frequently Asked Questions
- What is Medtronic's allowance for doubtful accounts receivable (current)?
- Medtronic (MDT) reported allowance for doubtful accounts receivable (current) of $207.00M in Q4 2025.
- How has Medtronic's allowance for doubtful accounts receivable (current) changed year-over-year?
- Medtronic's allowance for doubtful accounts receivable (current) increased by 1.5% year-over-year, from $204.00M to $207.00M.
- What is the long-term trend for Medtronic's allowance for doubtful accounts receivable (current)?
- Over 4 years (2021 to 2025), Medtronic's allowance for doubtful accounts receivable (current) has grown at a -4.7% compound annual growth rate (CAGR), from $241.00M to $199.00M.
- What does allowance for doubtful accounts receivable (current) mean?
- The estimated portion of customer invoices that the company expects will never be paid.